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bilization compared to the control group by ISH and qPCR. The expression
was not changed after immobilization compared to the control group by
IHC and WB. Expressions of CTGF and TGF-β1were increased after the ﬁrst
2-week immobilization and then decreased by ISH, and increased gradually
by IHC compared to the control group.
Conclusions: The expression of mRNAand protein levels of collagen types
I and III were not increased after immobilization, which indicated that
accumulation of the two types of collagen was not the etiology of joint
contracture. However, ﬁborogenetic factors of CTGF and TGF-β1 were
increased. Another process, such as capsule and synovial adhesions or
collagen cross-linking, may be possible causes of joint contracture.
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PROSTAGLANDIN D2 ENHANCES INTERLEUKIN -1BETA- INDUCED
CYCLOOXYGENASE-2 EXPRESSION IN OSTEOARTHRITIC SYNOVIOCYTES
N. Zayed, N. Chabane, F. El Mansouri, J. Martel-pelletier, J.-P. Pelletier,
h. Fahmi
Montreal Univ., Montreal, QC, Canada
Purpose: To investigate the effects of prostaglandin D2 (PGD2) on
interleukin-1beta (IL-1beta)-induced cyclooxygenase (COX)-2 expression
in human synoviocytes and the signalling pathways involved in these
effects.
Methods: Synoviocytes were stimulated with IL-1 in the presence or
absence of PGD2, and expression of COX-2 protein was evaluated by
western-blotting. Messenger RNA (mRNA) expression was analyzed by
real-time reverse transcription-polymerase chain reaction. The role of
the PGD2 receptors D prostanoid receptor 1 (DP1) and chemoattractant
receptor-like molecule expressed on Th2 cells (CRTH2) was evaluated using
speciﬁc agonists.
Results: PGD2 increased in a dose-dependent manner IL-1-induced COX-2
protein and mRNA expression. DP1 and CRTH2 were expressed and func-
tional in synoviocytes. The effect of PGD2 was mimicked by DK-PGD2 and
Indomethacin, selective agonists of CRTH2, but not by BW245C, a selective
agonist of DP1. Furthermore, treatment with an anti-CRTH2 antibody re-
versed the effect of PGD2, indicating that the stimulatory effect of PGD2
is mediated by CRTH2. Activation of CRTH2 is consistent with the activa-
tion of a receptor coupled to a phosphoinositide-speciﬁc phospholipase,
suggesting that the effect of PGD2 is mediated by the CRTH2/PIP2/PKC.
Conclusions: PGD2 enhances IL-1-induced production of COX-2 by syn-
oviocytes through the CRTH2/PIP2/PKC signalling pathway.
Matrix Biochemistry
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ELEVATED LEVELS OF COLLAGEN TYPE III IN ARTICULAR CARTILAGE OF
OSTEOARTHRITIC JOINTS
S. Hosseininia1 , L. Dahlberg1, L. Kim2, S. Funk2, M. Weis2, D. Eyre2
1Lund Univ., Malmö, Sweden; 2Univ. of Washington, Seattle, WA
Purpose: To determine differences between well-deﬁned OA and control
human articular cartilage samples in type III collagen content.
Methods: Full-depth, intact surface cartilage from 5 OA (aged 60-80, 4
women) and 5 reference (aged 78-87, 5 women) femoral heads were
obtained at total hip replacement surgery for osteoarthritis (OA) or femoral
neck fracture.
1 mg/ml α-chymotrypsin plus inhibitors was added to each diced sample
(incubated at 32°C overnight) to remove susceptible collagen components.
An aliquot of the supernatant was freeze-dried and used for SDS-PAGE
and another aliquot was hydrolyzed in 6M HCl at 110°C to be assayed for
hydroxyproline (μg/mg wet wt.) colorimetrically.
SDS-PAGE and Western blots were run using mAb 1C10, which recognizes
a sequence-speciﬁc epitope in α1(II) CB9,7 and mAb 4G9, which recognizes
a conformational epitope in the collagen III N-propeptide domain.
A competition ELISA was run on the same extracts using the 4G9 mAb
to quantify the collagen III N-propeptide levels extracted from OA and
reference cartilage samples.
Results: There was more extractable collagen in the OA than in the
reference cartilage, 5% and 2%, respectively (p=0.02).
From OA and normals, most of the extracted collagen ran as intact α1(II)
chains and large fragments on mAb 1C10 SDS-PAGE/Western (Fig. 2A).
Figure 1. Model of Type III collagen polymerized on Type II collagen ﬁbrils.
The major band stained in the SDS-PAGE/4G9 Western blot is the
cleaved N-propeptide trimer of collagen III released from the matrix by
α-chymotrypsin (Fig. 2B).
The ELISA results show a ﬁve-fold higher mean content of type III collagen
in OA hip cartilage versus fracture hip controls (Fig. 2B).
Figure 2. A. SDS-PAGE/Western blot of collagen type II in articular cartilage chy-
motrypsin extracts. B. SDS-PAGE/Western blot and an ELISA analysis of collagen type III
N-propeptide domain released from articular cartilage by chymotrypsin.
Conclusions: Our study conﬁrms previous results showing an increased
pool of extractable collagen in OA. In the present study we additionally
show that this extractable pool includes degradation products of type III
collagen.
The results show that grossly normal looking cartilage from joints under-
going degenerative disease (OA) develops a signiﬁcantly altered collagen
phenotype as shown by the synthesized and deposited collagen III in the
matrix of the OA compared with non-OA joints of similar age.
Previously it has been suggested that collagen III is made by the condro-
cytes in response to matrix damage similar to the wound-healing role of
collagen III in type I collagen-based tissues.
The covalent addition of collagen III to the ﬁbrillar matrix that occurs
in both normal and OA human articular cartilage suggests an active
remodeling process.
It remains to be established if increased amount of collagen III at sites of
superﬁcially intact, full thickness OA cartilage reﬂects pathological activity,
an active repair mechanism or both.
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INFRAPATELLAR FAT PAD CAN INDUCE FIBROTIC PROCESSES IN
CULTURED SYNOVIOCYTES
Y.M. Bastiaansen-Jenniskens1 , R. Stoop2, C. Feijt1, J. Verhaar1,
R. Hanemaaijer3, G. van Osch1
1Erasmus MC, Univ. Med. Ctr., Rotterdam, Netherlands; 2TNO Quality of Life,
Leiden, Netherlands; 3TNO Quality of Live, Leiden, Netherlands
Purpose: Stiffening of the joint is one of the features of knee osteoarthritis,
which can be caused by ﬁbrosis of the synovial tissue within the joint.
In this study, we investigated whether the adipose tissue in the joint
(infrapatellar fat pad) excretes cytokines and growth factors that could be
involved in ﬁbrosis.
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Methods: Fat conditioned medium (FCM) was made by culturing small
pieces of infrapatellar fat in medium for 24 hours. The fat was obtained
from osteoarthritic knees during total knee replacement. P2 synoviocytes,
isolated from synovium obtained during total knee replacement, were
seeded in high density and cultured in 9 different batches of FCM, rep-
resenting different infrapatellar fat pad donors. Synoviocytes were also
cultured in 10 ng/ml TGFβ1 as positive control. After 1 day, gene expression
of myoﬁbroblast markers PLOD2 (a cross-linking enzyme), α-smooth mus-
cle actin (αSMA) and collagen type I was determined, after 4 days collagen
content was measured. Furthermore, effects of FCM on proliferation (d1,
4, 5) and migration of the synoviocytes (scratch-wound assay, after 16
hours) were analyzed. Fat was also processed for immunodetection of
CD68 (macrophages), CD86 (classically activated macrophages) and CD206
(alternatively activated macrophages).
Results: Fat Conditioned Medium induced synoviocytes to produce signif-
icantly more collagen (Figure 1) and express more PLOD2 (Figure 2) than
when cultured in control medium. No clear effects were seen on collagen
type I and αSMA gene expression. Synoviocytes cultured in FCM had a
higher proliferation rate and migrated faster. Large numbers of CD68+ and
CD206+ cells were present in the fat tissue. CD86+ cells were present in
lower numbers.
Figure 1. Collagen production by synoviocytes in monolayer. Average effect of 9 different
batches of FCM is shown. *Indicates p<0.05.
Figure 2. PLOD2 gene expression by synoviocytes in monolayer. Average effect of 9 dif-
ferent batches of FCM is shown. *Indicates p<0.05, **indicates p<0.01.
Conclusions: In conclusion, infrapatellar fat produces factors that can
contribute to the development of synovial ﬁbrosis by increasing collagen
production, PLOD2 gene expression, cell proliferation and cell migration,
all characteristics of a ﬁbrotic process. A possible source for these factors
could be the many alternatively activated (or wound healing) macrophages
that were present in the fat tissue, since these cells are thought to be
involved in tissue repair.
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MODULATION OF HYALURONIC ACID SYNTHESIS BY COLLAGEN
HYDROLYSATES IN RABBIT SYNOVIOCYTES (HIG-82)
N. Yoshihiro, W. Mutsuto
Tokyo Univ. Agriculture & Technology, Tokyo, Japan
Purpose: Collagen hydrolysate (CH) has been used as one of the func-
tional foods for joint health. Some clinical studies have shown that oral
ingestion of CH exerted its beneﬁcial effect on OA symptoms. However,
the eﬃcacy of collagen-derived peptides has not been tested in clinical
studies. So the therapeutic mechanisms remain unclear. There are sev-
eral types of hydroxyproline (Hyp) -containing peptides in human blood
after orally administered CH. Therefore we assessed whether CH-derived
peptides and amino acids would inﬂuence hyaluronan (HA) synthesis in
synoviocytes.
Methods: Rabbit synovial ﬁbroblasts (HIG-82) were cultured in F-12
medium with 10%FBS. After 2 days, culture medium was replaced with
serum free F-12 medium containing Gly-Pro-Hyp, Pro-Hyp, Hyp (50μg/ml)
and incubated for 24h (RNA extraction) or 48h (HA assay). RT-PCR was
performed to determine mRNA levels of hyaluronan synthases (HAS-1
and HAS-2). Culture medium was harvested for HA assay. HA content
was measured by cellulose acetate membrane electrophoresis. Molecular
weight of HA was estimated by agarose gel electrophoresis.
Results: Gly-Pro-Hyp and Pro-Hyp signiﬁcantly up-regulated HAS-1 mRNA
level in HIG-82 cells. Hyp treatment depressed markedly HAS-2 mRNA
expression. But the amount of HA in the culture medium was not changed
after the treatment of Gly-Pro-Hyp and Hyp. Pro-Hyp signiﬁcantly stimu-
lated the secretion of HA. The concentration of HA with a molecular weight
greater than 700 kDa in the medium was higher in the presence of Hyp
Conclusions: Collagen hydrolysate-derived peptides enhanced HA synthe-
sis in synoviocytes. This phenomenon is associated with increase of HAS-1
mRNA expression. In contrast, amino acid Hyp depressed HAS-2 mRNA
expression. But HA content in the medium was not changed, and the
molecular weight of HA signiﬁcantly increased after Hyp treatment. These
ﬁndings suggest that oral ingestion of CH may exert its beneﬁcial effect
on OA symptoms through increased high molecular weight-HA production
into the synovial ﬂuid.
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THE REGULATION OF THE ADAMTS4 AND ADAMTS5 AGGRECANASES IN
OSTEOARTHRITIS
J. Bondeson1 , S.D. Wainwright2, C. Hughes2, B. Caterson2
1Dept. of Rheumatology, Cardiff, United Kingdom; 2Connective Tissue Biology
Lab., Cardiff Sch. of BioSci., Cardiff, United Kingdom
Purpose: To investigate the regulation of the ADAMTS4 and ADAMTS5 ag-
grecanases in human osteoarthritis (OA) synovium, with regard to cytokine
stimulation with IL-1 and/or TNFalpha, and also the degree of NFkappaB
dependence.
Methods: To investigate the role of TNFalpha and IL-1 in driving ADAMTS4
and ADAMTS5 expression in the human OA synovium, we used a model of
cultures of synovial cells from digested human OA synovium. It was possi-
ble to effectively and speciﬁcally neutralize the endogenous production of
IL-1beta and/or TNFalpha from the OA synovial macrophages. Cultures were
either left untreated, incubated with the p75 TNF soluble receptor Ig fusion
protein etanercept (Enbrel), incubated with a neutralizing anti-IL-1beta
antibody, or incubated with a combination of Enbrel and anti-IL-1beta.
After incubation for 48 h, cells were washed and RNA extracted using
Tri-reagent, to be taken to RT-PCR analysis using oligonucleotide primers
speciﬁc for ADAMTS4 and ADAMTS5, with GAPDH used for comparison of
gene expression.
The experiments with regard to the degree of NFkappaB dependence of
ADAMTS4 and ADAMTS5 made use of outgrown human OA synovial ﬁbrob-
lasts. Treatment with IL-1beta or TNFalpha, but not treatment with phorbol
ester, resulted in upregulation of ADAMTS4, whereas ADAMTS5 was un-
affected by these stimuli. In this model, it was possible to use adenoviral
gene transfer of the endogenous inhibitor IkappaBalpha to speciﬁcally
inhibit NFkappaB, without affecting other intracellular signalling pathways,
or inducing signiﬁcant apoptosis.
Results: In OA synovial cell cocultures, there was no effect of either
Enbrel or the neutralizing anti-IL-1beta antibody on ADAMTS5 expression,
nor was this aggrecanase at all affected by a combination of these treat-
ments. Thus ADAMTS5 appears to be constitutive in OA synovial cells.
In contrast, ADAMTS4 was signiﬁcantly (p<0.05) inhibited by Enbrel, and
more potently (p<0.01) inhibited by a combination of Enbrel and the
neutralizing anti-IL-1beta antibody. This would indicate that in the human
OA synovium, the upregulation of ADAMTS4 is dependent on TNFalpha and
IL-1 produced by the synovial macrophages, whereas the level of ADAMTS5
is not changed by these cytokines.
In OA synovial ﬁbroblasts, ADAMTS5 gene expression was not changed by
adenoviral gene transfer of IkappaBalpha, irrespective of stimulus used.
In contrast, ADAMTS4 induction by IL-1beta or TNFalpha was potently
inhibited by NFkappaB downregulation.
Conclusions: Although both ADAMTS4 and ADAMTS5 cleave aggrecanase,
